Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
PTUPB
Cat. No.:
OB0425LY-076
Appearance:
Solid
Purity:
98.69%
Identity:
Confirmed by LC-MS.
Size:
Add to basket
Product Overview
Description:
PTUPB is a high-quality dual sEH and COX-2 enzymes inhibitor.
Synonyms:
1287761-01-6; 4-(5-Phenyl-3-(3-(3-(4-(trifluoromethyl)phenyl)ureido)propyl)-1H-pyrazol-1-yl)benzenesulfonamide; 1-[3-[5-Phenyl-1-(4-sulfamoylphenyl)pyrazol-3-yl]propyl]-3-[4-(trifluoromethyl)phenyl]urea; 4-(5-Phenyl-3-[3-[3-(4-trifluoromethyl-phenyl)-ureido]-propyl]-pyrazol-1-yl)benzenesulfonamide
CAS No.:
1287761-01-6
Compound CID:
52951990
Formula:
C26H24F3N5O3S
Formula Weight:
543.56
Specification
Target:
COX
Pathway:
Immunology/Inflammation
Storage:
Storage at -20°C.
Applications:
PTUPB can be used to study cell signaling, obesity biology, or other roles in disease models.
